{"id":733,"date":"2017-06-14T14:54:26","date_gmt":"2017-06-14T13:54:26","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=733"},"modified":"2017-06-14T14:54:26","modified_gmt":"2017-06-14T13:54:26","slug":"glaxosmithkline-recall-almost-600000-asthma-inhalers","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/glaxosmithkline-recall-almost-600000-asthma-inhalers","title":{"rendered":"GlaxoSmithKline to recall almost 600,000 asthma inhalers"},"content":{"rendered":"

Pharmaceutical company GlaxoSmithKline (GSK) are recalling hundreds of thousands of reportedly defective asthma inhalers.<\/p>\n

The life-saving medical devices help asthma sufferers breathe, especially when suffering from asthma attacks, but a reported defect in the Ventolin inhalers has been found to provide insufficient doses.<\/p>\n

The drug company, based in the U.K., supplies asthma inhalers to hospitals, pharmacies, retailers and wholesalers around the world, with defective units being found in the U.S.
\n<\/p>\n

The recall<\/h2>\n

GSK was made aware of numerous reports that inhalers had a bulge on the outside wrapper. This seems to indicate that the medicine inside is leaking out of the container and therefore may not be able to deliver a sufficient dose as expected.<\/p>\n

It’s thought that a defect in the propellant causes the leak. In light of these concerns, GSK has so far issued a voluntary recall for some 593,000 inhalers thought to be affected by the problem.<\/p>\n

The products affected by the recall are:<\/p>\n

\n